We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Beneficial Effects of Control-IQ Automated Insulin Delivery in Basal-Bolus and Basal-Only Insulin Users With Type 2 Diabetes.
- Authors
Levy, Carol J.; Raghinaru, Dan; Kudva, Yogish C.; Pandit, Keta; Blevins, Thomas; Casaubon, Luis; Desjardins, Donna; Levister, Camilla M.; O’Malley, Grenye; Reid, Corey; Lum, John; Kollman, Craig; Beck, Roy W.
- Abstract
The t:slim X2 insulin pump with Control-IQ technology (Control-IQ) advanced hybrid closed-loop automated insulin delivery system was evaluated in this prospective single-arm trial. Thirty adults with type 2 diabetes using the Control-IQ system showed substantial glycemic improvement with no increase in hypoglycemia. Mean time in range (70–180 mg/dL) improved 15%, representing an increase of 3.6 hours/day, and mean glucose decreased by 22 mg/dL.
- Subjects
UNITED States; RESEARCH; CLINICAL trials; CONFIDENCE intervals; HYPOGLYCEMIC agents; TYPE 2 diabetes; INSULIN; TREATMENT effectiveness; COMPARATIVE studies; T-test (Statistics); INSULIN pumps; RESEARCH funding; DESCRIPTIVE statistics; QUESTIONNAIRES; DATA analysis software; PATIENT safety; LONGITUDINAL method
- Publication
Clinical Diabetes, 2024, Vol 42, Issue 1, p116
- ISSN
0891-8929
- Publication type
Article
- DOI
10.2337/cd23-0025